Retail Employees Superannuation Pty Ltd as trustee for Retail Employees Superannuation Trust purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 15,679 shares of the semiconductor company's stock, valued at approximately $7,365,000. Synopsys accounts for approximately 2.0% of Retail Employees Superannuation Pty Ltd as trustee for Retail Employees Superannuation Trust's investment portfolio, making the stock its 21st biggest position.
Other hedge funds and other institutional investors have also modified their holdings of the company. Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Synopsys in the 4th quarter valued at $28,000. Oakworth Capital Inc. boosted its position in shares of Synopsys by 3,700.0% in the 4th quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company's stock valued at $36,000 after purchasing an additional 74 shares during the period. KERR FINANCIAL PLANNING Corp acquired a new position in shares of Synopsys in the 3rd quarter valued at $38,000. N.E.W. Advisory Services LLC boosted its position in shares of Synopsys by 128.6% in the 4th quarter. N.E.W. Advisory Services LLC now owns 80 shares of the semiconductor company's stock valued at $38,000 after purchasing an additional 45 shares during the period. Finally, WealthCollab LLC boosted its position in shares of Synopsys by 110.8% in the 3rd quarter. WealthCollab LLC now owns 78 shares of the semiconductor company's stock valued at $38,000 after purchasing an additional 41 shares during the period. Institutional investors and hedge funds own 85.47% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages have commented on SNPS. Citigroup raised their price objective on Synopsys from $580.00 to $600.00 and gave the stock a "buy" rating in a research report on Wednesday, May 13th. Morgan Stanley restated an "equal weight" rating and set a $480.00 price objective (down from $550.00) on shares of Synopsys in a research report on Wednesday, February 25th. Needham & Company LLC restated a "buy" rating on shares of Synopsys in a research report on Thursday, February 26th. Rosenblatt Securities raised their price objective on Synopsys from $530.00 to $575.00 and gave the stock a "buy" rating in a research report on Tuesday. Finally, Berenberg Bank set a $633.00 price objective on Synopsys in a research report on Wednesday. Eight equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, Synopsys presently has an average rating of "Hold" and a consensus target price of $544.88.
View Our Latest Stock Report on SNPS
Synopsys Stock Down 1.6%
Shares of Synopsys stock opened at $525.92 on Thursday. The firm has a market cap of $100.75 billion, a price-to-earnings ratio of 81.66, a P/E/G ratio of 4.38 and a beta of 1.25. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26. Synopsys, Inc. has a 52-week low of $376.18 and a 52-week high of $651.73. The stock has a 50-day simple moving average of $457.56 and a 200-day simple moving average of $453.69.
Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.15 by $0.20. The business had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The firm's revenue was up 41.9% on a year-over-year basis. During the same period in the previous year, the company earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, equities research analysts expect that Synopsys, Inc. will post 10.28 earnings per share for the current fiscal year.
Synopsys News Roundup
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys beat Q2 expectations, reporting non-GAAP EPS of $3.35 versus estimates around $3.17 and revenue of $2.276 billion versus consensus near $2.25 billion, showing continued demand for its chip design software. Reuters article
- Positive Sentiment: The company raised FY2026 guidance, now projecting EPS of $14.72 to $14.80 and revenue of roughly $9.6 billion to $9.7 billion, signaling confidence in AI-driven demand and operating momentum. Press release
- Positive Sentiment: Synopsys reached a cooperation agreement with Elliott Investment Management and added Elliott partner Jesse Cohn to its board, which could support efforts to improve margins, governance, and shareholder value. Reuters article
- Neutral Sentiment: Despite the strong report, the stock is reacting cautiously, suggesting some investors may be taking profits after a large run-up and waiting for proof that growth can hold up after the Ansys-related integration and portfolio changes.
- Negative Sentiment: The market may be weighing that Q2 EPS of $3.35 was still below the prior-year $3.67, which can temper enthusiasm even with a beat versus estimates. Zacks article
About Synopsys
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.